Publicaciones
-
Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.
Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
Oncotarget . 7(13): 16112-16129. Nº de citas: 16
-
Johann PD, Erkek S, Zapatka M, Kerl K, Buchhalter I, Hovestadt V, Jones DT, Sturm D, Hermann C, Segura Wang M, Korshunov A, Rhyzova M, Gröbner S, Brabetz S, Chavez L, Bens S, Gröschel S, Kratochwil F, Wittmann A, Sieber L, Geörg C, Wolf S, Beck K, Oyen F, Capper D, van Sluis P, Volckmann R, Koster J, Versteeg R, von Deimling A, Milde T, Witt O, Kulozik AE, Ebinger M, Shalaby T, Grotzer M, Sumerauer D, Zamecnik J, Mora J, Jabado N, Taylor MD, Huang A, Aronica E, Bertoni A, Radlwimmer B, Pietsch T, Schüller U, Schneppenheim R, Northcott PA, Korbel JO, Siebert R, Frühwald MC, Lichter P, Eils R, Gajjar A, Hasselblatt M, Pfister SM and Kool M.
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
Cancer Cell . 29(3): 379-393. Nº de citas: 401
-
Kovar H, Amatruda J, Brunet E, Burdach S, Cidre-Aranaz F, de Alava E, Dirksen U, van der Ent W, Grohar P, Grünewald TG, Helman L, Houghton P, Iljin K, Korsching E, Ladanyi M, Lawlor E, Lessnick S, Ludwig J, Meltzer P, Metzler M, Mora J, Moriggl R, Nakamura T, Papamarkou T, Radic Sarikas B, Rédini F, Richter GH, Rossig C, Schadler K, Schäfer BW, Scotlandi K, Sheffield NC, Shelat A, Snaar-Jagalska E, Sorensen P, Stegmaier K, Stewart E, Sweet-Cordero A, Szuhai K, Tirado OM, Tirode F, Toretsky J, Tsafou K, Üren A, Zinovyev A and Delattre O.
The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease
Oncotarget . 7(8): 8613-8624. Nº de citas: 33
-
Monterrubio C, Pascual-Pastó G, Cano F, Vilà-Ubach M, Manzanares-Quintela A, Schaiquevich P, Tornero JA, Sosnik A, Mora J and Carcaboso AM.
SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery
Biomaterials . 79: 69-78. Nº de citas: 40
-
Rosé A, André N, Rozados VR, Mainetti LE, Márquez MM, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Mora J, García WG, Epelman S, Alasino C, Alonso D, Chantada G and Scharovsky OG.
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.
ecancermedicalscience . 10: 672-672. Nº de citas: 10
-
Mora J, Suñol M, Rodriguez E and de Torres C.
Vascular tumors preceding Ewing sarcoma: clinico-pathological observations
Sarcoma Research International . 2(3): 1021.
-
Pérez-Jaume S and Carrasco JL.
A non-parametric approach to estimate the total deviation index for non-normal data
STATISTICS IN MEDICINE . 34(25): 3318-3335. Nº de citas: 4
-
Garzón M, García-Fructuoso G, Suñol M, Mora J and Cruz-Martínez O.
Low-grade gliomas in children: single institutional experience in 198 cases
CHILDS NERVOUS SYSTEM . 31(9): 1447-1459. Nº de citas: 8
-
Monterrubio C, Paco-Mercader S, Vilà-Ubach M, Rodriguez E, Glisoni R, Lavarino C, Schaiquevich P, Sosnik A, Mora J and Carcaboso AM.
Combined Microdialysis-Tumor Homogenate Method for the Study of the Steady State Compartmental Distribution of a Hydrophobic Anticancer Drug in Patient-Derived Xenografts
PHARMACEUTICAL RESEARCH . 32(9): 2889-2900. Nº de citas: 10
-
Ordóñez JL, Amaral AT, Carcaboso AM, Herrero-Martín D, Del Carmen García-Macías M, Sevillano V, Alonso D, Pascual-Pastó G, San-Segundo L, Vilà-Ubach M, Rodrigues T, Fraile S, Teodosio C, Mayo-Iscar A, Aracil M, Galmarini CM, Tirado OM, Mora J and de Álava E.
The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin
Oncotarget . 6(22): 18875-18890. Nº de citas: 64